Fed. Circ. Upholds Ruling Against Generic Acular
A federal appeals court has affirmed a lower court ruling that barred Apotex Inc. from obtaining regulatory approval to market a generic version of Allergan Inc.'s prescription anti-inflammatory eye-drop solution Acular....To view the full article, register now.
Already a subscriber? Click here to view full article